Resolute Advisors LLC Abb Vie Inc. Transaction History

Resolute Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $48,236 - $61,032	-449 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $3,936 - $4,468	37 Added 8.98%	449 $48,000
Q2 2021 Dec 27, 2021	BUY	$105.21 - $117.21 $43,346 - $48,290	412 New	412 $46,000
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $43,346 - $48,290	-412 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$102.3 - $112.62 $42,147 - $46,399	412 New	412 $34,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.